Metabiomed Co Ltd
KOSDAQ:059210
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Metabiomed Co Ltd
Tax Provision
Metabiomed Co Ltd
Tax Provision Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Metabiomed Co Ltd
KOSDAQ:059210
|
Tax Provision
-₩3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Suheung Co Ltd
KRX:008490
|
Tax Provision
-₩6.6B
|
CAGR 3-Years
16%
|
CAGR 5-Years
12%
|
CAGR 10-Years
-11%
|
|
|
SD Biosensor Inc
KRX:137310
|
Tax Provision
₩121B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
165%
|
CAGR 10-Years
N/A
|
|
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
Tax Provision
-₩153.1m
|
CAGR 3-Years
65%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
H
|
HLB Inc
KOSDAQ:028300
|
Tax Provision
₩5.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
T
|
T&L Co Ltd
KOSDAQ:340570
|
Tax Provision
-₩15.9B
|
CAGR 3-Years
-60%
|
CAGR 5-Years
-71%
|
CAGR 10-Years
N/A
|
|
Metabiomed Co Ltd
Glance View
Meta Biomed Co., Ltd. engages in the manufacture and sale of surgical and other medical devices. The company is headquartered in Cheongju, Chungcheongbuk-Do. The company went IPO on 2008-04-15. The firm mainly operates its business through three divisions: suture material division, dental division and bone material division. Its suture material division provides suture materials, such as polyglycolic acid (PGA) synthetic absorbable braids, polyglycolic acid-co-lactic acid (PGLA) absorbable braids, polydioxanone (PDO) synthetic absorbable monofilaments, polyglycolide-co-epsilon-caprolactone (PGCL) synthetic absorbable monofilaments and others. Its dental division provides dental materials and equipment, such as gutta percha cordless obturation systems, electronic apex locators, taper points, root canal sealers, root canal filling materials and others. Its bone materials division provides bone graft substitutes. The company also distributes dental-related products.
See Also
What is Metabiomed Co Ltd's Tax Provision?
Tax Provision
-3B
KRW
Based on the financial report for Sep 30, 2025, Metabiomed Co Ltd's Tax Provision amounts to -3B KRW.
